Mirati Therapeutics

red and yellow background with scissors
Biotech

BMS removes 2 clinical programs from pipeline

BMS is shedding two clinical programs from its wholly owned pipeline, one from its Mirati buyout and another from a partnership with Exscientia.
Gabrielle Masson Oct 30, 2025 1:14pm
Graphic image of a man climbing up a latter in front of a beige background with clouds and a blue splotch of sky

Charles Baum takes over Terremoto as CEO

Jul 25, 2024 11:55am
Photo of a parachutes opened with a dark blue sky in the background

John Cox gets new biotech CEO gig at Dyne—Chutes & Ladders

Mar 29, 2024 9:30am
Palm tree branches bending as storm clouds approach

Frontier CEO weathers one of his hardest fundraises to add $80M

Feb 22, 2024 4:01pm
Merck MSD ESMO 2023

Merck's early KRAS data suggest combination-friendly safety

Oct 23, 2023 9:45am
A histology stain of pancreatic ductal adenocarcinoma

KRAS inhibitor, immunotherapy halts pancreatic cancer in mice

Aug 29, 2023 9:56am